c-Ki-ras Gene Mutations in Ulcerative Colitis Carcinomas
Author Information
Author(s): S.M. Bell, S.A. Kelly, J.A. Hoyle, F.A. Lewis, G.R. Taylor, H. Thompson, M.F. Dixon, P. Quirkel
Primary Institution: University of Leeds
Hypothesis
Are there differences in c-Ki-ras mutations between carcinomas arising in ulcerative colitis and sporadic colorectal carcinomas?
Conclusion
The study found that c-Ki-ras mutations occur at a lower frequency in ulcerative colitis carcinomas compared to sporadic colorectal carcinomas.
Supporting Evidence
- 42% of sporadic carcinoma controls had Ki-ras codon 12 mutations.
- 24% of ulcerative colitis carcinomas contained Ki-ras mutations.
- 72% of sporadic rectal carcinomas had c-Ki-ras mutations compared to 9% in UC rectal carcinomas.
- Significant differences in mutation rates suggest genetic differences in cancer development.
Takeaway
This study looked at cancer samples from patients with ulcerative colitis and found that a specific gene mutation happens less often in their cancers compared to other types of colon cancer.
Methodology
DNA was extracted from paraffin-embedded samples and analyzed for c-Ki-ras mutations using PCR and restriction enzyme digestion.
Limitations
The study may not account for all genetic differences as it focused only on c-Ki-ras mutations at codons 12 and 13.
Participant Demographics
The study included 26 patients with ulcerative colitis and matched controls with sporadic colorectal carcinoma.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.04
Want to read the original?
Access the complete publication on the publisher's website